Renejix Pharma Solutions

Renejix is a leading CDMO accelerating the development and manufacturing of critical new medicines in the small molecule oral dosage space. We combine cutting-edge technologies with a team of highly skilled experts to deliver top-notch solutions for oral small molecule development and manufacturing. With a focus on innovation, quality, and efficiency in development sciences, delivery technologies, and multi-modality manufacturing we are dedicated to helping our clients bring their molecules from concept to commercialization

Cdmo,manufacturing,solid dosage,anlaytical services,regulatory,clinical,clinical manufacturing,stability & storage,scale up,technology transfers,drug delivery systems,bioavailability enhancement,r&d,formulation,clinical supply,development & bioavalibility,commercial manufacturing,small molecules,oral dosage,topical dosage,transdermal dosage,controlled substances,hpapi,liquids,solids,semi-solids,capsules,tablets,softgels,patches,nanotechnology,and modified release

Renejix pharma solutions operates in the Pharmaceutical manufacturing industry.

Renejix pharma solutions's revenue is 11m - 100m

Renejix pharma solutions has 11 - 50 employees.